Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism ERK1 inhibitors(Extracellular-signal-regulated kinase1 inhibitors), ERK2 inhibitors(Extracellular-signal-regulated kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced cancer | Phase 2 | US | 23 Jan 2020 | |
Advanced cancer | Phase 2 | US | 23 Jan 2020 | |
Erdheim-Chester Disease | Phase 2 | US | 23 Jan 2020 | |
Erdheim-Chester Disease | Phase 2 | CN | 23 Jan 2020 | |
Melanoma | Phase 2 | US | 23 Jan 2020 | |
Melanoma | Phase 2 | CN | 23 Jan 2020 | |
Non-Small Cell Lung Cancer | Phase 2 | US | 23 Jan 2020 | |
Non-Small Cell Lung Cancer | Phase 2 | CN | 23 Jan 2020 |